Jeffrey H Samet, MD, MA, MPH
Professor, Community Health Sciences - Boston University School of Public Health
Biography
My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.
Other Positions
- Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
- Faculty, Medicine - Boston University Chobanian & Avedisian School of Medicine
Education
- Baylor College of Medicine, MD Field of Study: Medicine
- Boston University, MPH Field of Study: Epidemiology
- Brandeis University, MA Field of Study: Chemistry
- Brandeis University, BA
Publications
- Published on 10/11/2025
El-Bassel N, Samet JH, Cheng DM, Freisthler B, John Winhusen T, Walsh SL. Response to the Editor: Re: registration and multiple outcome testing in the HEALing Communities Study by Dennis M. Gorman and Ben G. Fitzpatrick. Int J Drug Policy. 2025 Nov; 145:105029. PMID: 41077014.
Read At: PubMed
- Published on 9/26/2025
Katz R, Fisher T, Singer-Clark T, Soares Iii W, Carpenter J, Schuessler N, Stadler H, Sahovey A, McAlearney AS, Samet JH, Chatterjee A. Creation of a telehealth addiction consultation service at a rural hospital: a case study. Addict Sci Clin Pract. 2025 Sep 26; 20(1):76. PMID: 41013782.
Read At: PubMed
- Published on 8/1/2025
Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH. High-Dose Buprenorphine Treatment in the Setting of Fentanyl. JAMA Netw Open. 2025 Aug 01; 8(8):e2528119. PMID: 40839262.
Read At: PubMed
- Published on 7/29/2025
Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G, Hann J, Dionne JC, Ahmed A, Kim D, Nolan S, Thabane L, Samaan Z, Dennis BB. Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study. Drug Alcohol Depend Rep. 2025 Sep; 16:100368. PMID: 40837618.
Read At: PubMed
- Published on 7/9/2025
Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.
Read At: PubMed
- Published on 7/3/2025
Tilhou AS, Assoumou SA, Samet JH. Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. J Gen Intern Med. 2025 Jul 03. PMID: 40610667.
Read At: PubMed
- Published on 6/1/2025
Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.
Read At: PubMed
- Published on 5/26/2025
Levin FR, Oyler DR, Babineau DC, Villani J, Chandler RK, Freeman PR, Alford DP, Fareed N, Mack N, Nguyen TQ, Walker DM, Adams J, Baker TJ, Beers D, Benjamin SN, Bhuiyan J, Blevins D, David JL, Dalvi N, D'Costa L, Feaster DJ, Glasgow L, Goddard-Eckrich DA, Han Y, Harris M, Hunt T, Knott C, Matson A, Mierzwa F, Newman L, Nunes EV, Oga EA, Roberts MF, Shadwick A, Shoben A, Slavova S, Stinson L, Zarkin GA, Freisthler B, Samet JH, Walsh SL, Winhusen TJ, Jackson RD, El-Bassel N. Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing? AJPM Focus. 2025 Dec; 4(6):100371. PMID: 41035949.
Read At: PubMed
- Published on 4/25/2025
Chavez LJ, Yu O, Wartko PD, Braciszewski JM, Glass JE, Horigian VE, Arnsten JH, Murphy MT, Stotts AL, Bagley SM, Lapham GT, Samet JH. Opioid use disorder medications among youth in primary care: Subgroup analysis of the PROUD trial. Pediatr Open Sci. 2025; 1(2). PMID: 40718732.
Read At: PubMed
- Published on 4/11/2025
Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Jun; 140:104798. PMID: 40220509.
Read At: PubMed
View 484 more publications:View Full Profile at BUMC
News & In the Media
-
Published on July 11, 2025
Naltrexone for Alcohol Use Disorder May Work for Hospitalized Patients
- Published on April 21, 2025
-
Published on June 17, 2024
Ambitious Federal Effort to Curb Overdoses Shows No Impact on Deaths, Initial Study Finds
- Published on March 22, 2023
- Published on May 11, 2020
- Published on October 16, 2019
- Published on August 23, 2019
-
Published on August 7, 2019
As Scotland’s ‘Trainspotting’ Generation Ages, the Dead Pile Up
- Published on June 5, 2019
- Published on June 5, 2019
- Published on April 25, 2019
-
Published on April 24, 2019
Greenfield, Montague, Athol and Orange to Join in $89M National Opioid Study
-
Published on October 31, 2018
In Massachusetts, Nearly 5 Percent of People Over 11 Abuse Opioids
-
Published on October 31, 2018
Study: Nearly 5 Percent of Mass. Residents Struggle with Opioid Abuse
-
Published on October 26, 2018
New Study Suggests Opioid Addiction in Mass. Is Much Worse Than Thought
-
Published on October 26, 2018
Study: 4.6 Percent of Massachusetts Population Has Opioid Use Disorder
-
Published on October 26, 2018
Study: Nearly 6% of Bristol County, Mass. Residents Addicted to Opioids
-
Published on October 26, 2018
In Massachusetts, Almost 1 in 20 Adults and Older Kids Abuse Opioids
-
Published on October 26, 2018
Study: 4.6 Percent of Massachusetts Residents Have Opioid Use Disorder
-
Published on October 26, 2018
Nearly 1 in 20 Massachusetts Residents Has Opioid Use Disorder
-
Published on October 1, 2018
Alcohol Use Disorder Therapy Could Improve Chronic Liver Disease Outcomes
-
Published on July 6, 2018
Leaders Call Restricting Methadone Treatment to Clinic Settings Outdated